Summary of the article in simple terms:

Apollomics is a company that works on making new medicines. They got a message from Nasdaq, which is a big place where many companies' stocks are traded. The message says that Apollomics did not have enough money in their stock to meet the requirements for being listed there. This means they may lose their spot on Nasdaq and people might not be able to buy or sell their stock easily. Apollomics has some risks and uncertainties, which means things might not go as planned. They also talk about the future in their statements, but they cannot promise that everything will happen exactly how they say it will. Read from source...

- The headline is misleading and sensationalized. It implies that Apollomics has been officially notified by Nasdaq that it violated the minimum bid price rule, which would result in a delisting warning or suspension. However, the actual text states that Apollomics received a "notification regarding" this issue, which means that Nasdaq is informing them of their possible non-compliance and giving them an opportunity to address it before any action is taken. This creates uncertainty and doubt for investors and readers who may not understand the difference between a notification and a formal warning or suspension.